Baidu
map

传染科指南

订阅

MedSci主页 / 所有栏目 / 传染科指南

β内酰胺类抗菌药物皮肤试验指导原则（2021年版）

2021-04-13 中华人民共和国国家卫生健康委员会 国家卫生健康委

抗菌药

为进一步规范β内酰胺类抗菌药物皮肤试验的使用和判读,促进抗菌药物合理应用，我委委托国家卫生健康委抗菌药物临床应用与细菌耐药评价专家委员会制定了《β内酰胺类抗菌药物皮肤试验指导原则（

中文标题：

β内酰胺类抗菌药物皮肤试验指导原则（2021年版）

发布机构：

中华人民共和国国家卫生健康委员会

发布日期：

2021-04-13

简要介绍：

为进一步规范β内酰胺类抗菌药物皮肤试验的使用和判读,促进抗菌药物合理应用，我委委托国家卫生健康委抗菌药物临床应用与细菌耐药评价专家委员会制定了《β内酰胺类抗菌药物皮肤试验指导原则（2021年版）》。

相关资料下载：
[AttachmentFileName(sort=1, fileName=66.docx)] GetToolGuiderByIdResponse(projectId=1, id=cc1941c00209a999, title=β内酰胺类抗菌药物皮肤试验指导原则（2021年版）, enTitle=, guiderFrom=国家卫生健康委, authorId=0, author=, summary=为进一步规范&beta;内酰胺类抗菌药物皮肤试验的使用和判读,促进抗菌药物合理应用，我委委托国家卫生健康委抗菌药物临床应用与细菌耐药评价专家委员会制定了《&beta;内酰胺类抗菌药物皮肤试验指导原则（, cover=, journalId=0, articlesId=null, associationId=1653, associationName=中华人民共和国国家卫生健康委员会, associationIntro=, copyright=0, guiderPublishedTime=Tue Apr 13 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #484848;"><span style="color: #484848; font-family: 仿宋_GB2312;">为进一步规范</span><span style="color: #484848; font-family: 仿宋_GB2312;">&beta;内酰胺类</span></span><span style="color: #484848;">抗菌药物</span><span style="color: #484848;"><span style="color: #484848; font-family: 仿宋_GB2312;">皮肤试验的使用和判读</span><span style="color: #484848; font-family: 仿宋_GB2312;">,促进抗菌药物合理应用，</span></span><span style="color: #484848;">我委</span><span style="color: #484848;">委托</span><span style="color: #484848;">国家卫生健康委</span><span style="color: #484848;">抗菌药物临床应用与细菌耐药评价专家委员会</span><span style="color: #484848;">制定了</span><span style="color: #484848;"><span style="color: #484848; font-family: 仿宋_GB2312;">《</span><span style="color: #484848; font-family: 仿宋_GB2312;">&beta;内酰胺类</span></span><span style="color: #484848;">抗菌药物</span><span style="color: #484848;"><span style="color: #484848; font-family: 仿宋_GB2312;">皮肤试验指导原则（</span><span style="color: #484848; font-family: 仿宋_GB2312;">202</span></span><span style="color: #484848;">1</span><span style="color: #484848;">年版）》。</span></p>, tagList=[TagDto(tagId=1398, tagName=抗菌药)], categoryList=[CategoryDto(categoryId=9, categoryName=传染科, tenant=100), CategoryDto(categoryId=11, categoryName=药械, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指导原则, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=17447, appHits=155, showAppHits=0, pcHits=1330, showPcHits=17291, likes=1, shares=13, comments=7, approvalStatus=1, publishedTime=Thu May 13 20:16:22 CST 2021, publishedTimeString=2021-04-13, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Thu May 13 20:16:13 CST 2021, updatedBy=4754896, updatedName=fbzhang, updatedTime=Fri Jan 05 20:36:46 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.docx)])
66.docx
下载请点击：
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1181854, encodeId=996c118185482, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Fri Jan 07 14:52:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072964, encodeId=6dc510e2964af, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Mon Nov 22 21:03:01 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007729, encodeId=d2eb100e72911, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Fri Aug 13 22:03:19 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996467, encodeId=8ccb99646eb7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/6DF3543CA4B977270D8CE734D49C26BA/100, createdBy=690e2536078, createdName=妖妖0, createdTime=Mon Jul 05 17:25:08 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996114, encodeId=8dbc9961144f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/95a6dce31e174b2da437bbf0d7090c4c/18a48c44e42e4055ad2157fc5a9a4353.jpg, createdBy=b8865528278, createdName=litlco, createdTime=Sun Jul 04 15:47:27 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2022-01-07 ms7000000167247375

    学习#学习#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1181854, encodeId=996c118185482, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Fri Jan 07 14:52:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072964, encodeId=6dc510e2964af, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Mon Nov 22 21:03:01 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007729, encodeId=d2eb100e72911, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Fri Aug 13 22:03:19 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996467, encodeId=8ccb99646eb7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/6DF3543CA4B977270D8CE734D49C26BA/100, createdBy=690e2536078, createdName=妖妖0, createdTime=Mon Jul 05 17:25:08 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996114, encodeId=8dbc9961144f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/95a6dce31e174b2da437bbf0d7090c4c/18a48c44e42e4055ad2157fc5a9a4353.jpg, createdBy=b8865528278, createdName=litlco, createdTime=Sun Jul 04 15:47:27 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-11-22 谷芬

    好好好

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1181854, encodeId=996c118185482, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Fri Jan 07 14:52:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072964, encodeId=6dc510e2964af, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Mon Nov 22 21:03:01 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007729, encodeId=d2eb100e72911, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Fri Aug 13 22:03:19 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996467, encodeId=8ccb99646eb7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/6DF3543CA4B977270D8CE734D49C26BA/100, createdBy=690e2536078, createdName=妖妖0, createdTime=Mon Jul 05 17:25:08 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996114, encodeId=8dbc9961144f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/95a6dce31e174b2da437bbf0d7090c4c/18a48c44e42e4055ad2157fc5a9a4353.jpg, createdBy=b8865528278, createdName=litlco, createdTime=Sun Jul 04 15:47:27 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-08-13 1581f80970m

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1181854, encodeId=996c118185482, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Fri Jan 07 14:52:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072964, encodeId=6dc510e2964af, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Mon Nov 22 21:03:01 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007729, encodeId=d2eb100e72911, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Fri Aug 13 22:03:19 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996467, encodeId=8ccb99646eb7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/6DF3543CA4B977270D8CE734D49C26BA/100, createdBy=690e2536078, createdName=妖妖0, createdTime=Mon Jul 05 17:25:08 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996114, encodeId=8dbc9961144f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/95a6dce31e174b2da437bbf0d7090c4c/18a48c44e42e4055ad2157fc5a9a4353.jpg, createdBy=b8865528278, createdName=litlco, createdTime=Sun Jul 04 15:47:27 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-07-05 妖妖0

    学习了

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1181854, encodeId=996c118185482, content=学习<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=93, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=77af6451843, createdName=ms7000000167247375, createdTime=Fri Jan 07 14:52:00 CST 2022, time=2022-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1072964, encodeId=6dc510e2964af, content=好好好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=114, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=514d5556399, createdName=谷芬, createdTime=Mon Nov 22 21:03:01 CST 2021, time=2021-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007729, encodeId=d2eb100e72911, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=115, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f6512108074, createdName=1581f80970m, createdTime=Fri Aug 13 22:03:19 CST 2021, time=2021-08-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996467, encodeId=8ccb99646eb7, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/101296147/6DF3543CA4B977270D8CE734D49C26BA/100, createdBy=690e2536078, createdName=妖妖0, createdTime=Mon Jul 05 17:25:08 CST 2021, time=2021-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=996114, encodeId=8dbc9961144f, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210704/95a6dce31e174b2da437bbf0d7090c4c/18a48c44e42e4055ad2157fc5a9a4353.jpg, createdBy=b8865528278, createdName=litlco, createdTime=Sun Jul 04 15:47:27 CST 2021, time=2021-07-04, status=1, ipAttribution=)]
    2021-07-04 litlco

    学习了

    0

相关指南

抗菌药物研发立题技术指导原则

国家药品监督管理局药品审评中心（CDE） · 2019-10-31

中国中性粒细胞缺乏伴发热患者抗菌药物临床应用指南（2016年版）

中华医学会血液学分会(CMA,CHINESE MEDICAL ASSOCIATION) · 2016-05-20

Baidu
map
Baidu
map
Baidu
map